The Itch That Won't Quit: A Comprehensive Review of Urticaria

Registration ID: IJNRD_190100

Published ID: IJNRD2303471

: Click Here to Get

MD Nur Islam, Tamzid Hasan

Urticaria, Mast cell, Treatment, Prevention

Urticaria is a skin condition that is categorized based on the duration of symptoms and the presence or absence of triggers. Urticarial vasculitis, contact urticaria, and special syndromes fall under the broader classification of urticaria. In recent years, there has been progress in understanding the pathogenesis of chronic urticaria, with the discovery of autoantibodies to mast cell receptors in almost 50% of patients with chronic idiopathic urticaria. These patients often require more aggressive therapies due to the severity of their condition. However, laboratory tests for chronic urticaria usually do not reveal significant findings, and there is no clear association between urticaria and chronic infections or cancer.Treatment for urticaria usually involves the use of first- and second-generation histamine H1 receptor antihistamines. For more severe and persistent cases, additional therapy may include leukotriene receptor antagonists, corticosteroids, and immunomodulatory agents. Despite advancements in understanding the pathogenesis of urticaria, it remains a frustrating condition for many patients, particularly those with chronic urticaria. Although there have been advancements in understanding the pathogenesis of urticaria, the condition can still be challenging to manage, and patients may require multiple treatments to achieve relief of their symptoms. Additionally, the psychological impact of chronic urticaria should not be overlooked, as it can significantly affect patients' quality of life. As such, a multidisciplinary approach to management, including education and psychological support, can be beneficial in treating patients with urticaria.

Published Paper   E-Certificate

MD Nur Islam & Tamzid Hasan (March-2023). The Itch That Won't Quit: A Comprehensive Review of Urticaria. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(3), e558-e565. https://ijnrd.org/papers/IJNRD2303471.pdf

Volume 8 Issue 3, March-2023

Pages : e558-e565

Paper Reg. ID: IJNRD_190100

Published Paper Id: IJNRD2303471

Downloads: 000122018

Research Area: Pharmacy

Author Type: Indian Author

Country: vadodara, Gujarat, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2303471.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2303471

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details